Kurdikar Devdatt — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Kurdikar Devdatt has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Profile

Devdatt Kurdikar is the President and CEO of Embecta Corp, a company specializing in medical devices for diabetes management. He has also held the position of Director at Zimmer Biomet Holdings, Inc., contributing to the healthcare sector through leadership roles in both organizations.

Board memberships

• Embecta Corp
• Zimmer Biomet Holdings, Inc.

Awards & honors

• Leadership in diabetes management solutions
• Director at Zimmer Biomet Holdings, Inc.
• CEO of Embecta Corp

Recent Transactions

Companies — Last 90 Days

• ZIMMER BIOMET HOLDINGS, INC. (ZBH) — 2 filings, last 2026-07-02

Frequently Asked Questions

Who is Kurdikar Devdatt?

Devdatt Kurdikar is the President and CEO of Embecta Corp, a company specializing in medical devices for diabetes management. He has also held the position of Director at Zimmer Biomet Holdings, Inc., contributing to the healthcare sector through leadership roles in both organizations.…

How many SEC Form 4 filings has Kurdikar Devdatt submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Kurdikar Devdatt's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week